Algo version: 0.98b
Ascentage Pharma Group is listed at the HKSE Exchange
Ascentage Pharma Group [6855.HK]
HKSE Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Ascentage Pharma Group stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Ascentage Pharma Group 10 years ago, but if you had invested on Monday 28th of October 2019 when the price was HKD37.60, you would have made a loss of HKD-4.85 per share or -12.90%

Yes, the average daily trading liquidity for Ascentage Pharma Group is HKD1.50 million. You should therefore be able to get in and out of your positions relatively fast.

Ascentage Pharma Group has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Ascentage Pharma Group to be high [1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.